Welcome to CDC stacks | Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen - 35559 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
Filetype[PDF-274.98 KB]


No Related Documents.
You May Also Like:
  1. Multidrug-resistant Tuberculosis Management in Resource-limited Settings
    Personal Author:
    Nathanson, Eva; Lambregts-van Weezenbeek, Catharina; Rich, Michael L.; Gupta, Rajesh; Bayona, Jaime; Blöndal, Kai; Caminero, José A.; Cegielski, J. Peter; Danilovits, Manfred; Espinal, Marcos A.; Hollo, Vahur; Jaramillo, Ernesto; Leimane, Vaira; Mitnick, Carole D.; Mukherjee, Joia S.; Nunn, Paul; Pasechnikov, Alexander; Tupasi, Thelma; Wells, Charles; Raviglione, Mario C.;
    Published:
    Sep 2006
    Source:
    Emerg Infect Dis. 12(9):1389-1397.
    Description:
    Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philip...
    File Type:
    Filetype[PDF - 327.05 KB]
  2. Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008
    Personal Author:
    Velásquez, Gustavo E.; Yagui, Martin; Cegielski, J. Peter; Asencios, Luis; Bayona, Jaime; Bonilla, Cesar; Jave, Hector O.; Yale, Gloria; Suárez, Carmen; Atwood, Sidney; Contreras, Carmen C.; Shin, Sonya S.;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):432-440.
    Description:
    The Peruvian National Tuberculosis Control Program issued guidelines in 2006 specifying criteria for culture and drug-susceptibility testing (DST), including district-level rapid DST. All patients referred for culture and DST in 2 districts of Lima, ...
    File Type:
    Filetype[PDF - 235.05 KB]
  3. Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008
    Personal Author:
    Chen, Yi-Ting; Lee, Jen-Jyh; Chiang, Chen-Yuan; Yang, Gee-Gow; Tsai, Yeong-Chu; Lee, Yeong-Sheng; Lin, Chih-Bin;
    Published:
    Feb 23 2012
    Source:
    PLoS One. 2012; 7(2).
    Description:
    Background : The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance p...
    File Type:
    Filetype[PDF - 360.62 KB]
  4. Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand
    Personal Author:
    Anuwatnonthakate, Amornrat; Limsomboon, Pranom; Nateniyom, Sriprapa; Wattanaamornkiat, Wanpen; Komsakorn, Sittijate; Moolphate, Saiyud; Chiengsorn, Navarat; Kaewsa-ard, Samroui; Sombat, Potjaman; Siangphoe, Umaporn; Mock, Philip A.; Varma, Jay K.;
    Published:
    Aug 28 2008
    Source:
    PLoS ONE. 2008; 3(8).
    Description:
    Background : The World Health Organization (WHO) recommends that tuberculosis (TB) patients receive directly observed therapy (DOT). Randomized controlled trials have not consistently shown that this practice improves TB treatment success rates. In T...
    File Type:
    Filetype[PDF - 151.86 KB]
  5. Treatment of latent tuberculosis infection and tuberculosis disease
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    2016
    Series:
    Self-study modules on tuberculosis ; module 4
    Description:
    In this module, you will learn about the principles of treating latent TB infection (LTBI) and TB disease. A person with LTBI is treated to prevent them from progressing to TB disease. Some people with LTBI are at very high risk of developing TB dise...
    File Type:
    Filetype[PDF - 2.73 MB]